Sarepta Therapeutics (SRPT) PT Raised to $50 at BMO Capital
Tweet Send to a Friend
(Updated - July 29, 2025 6:55 AM EDT)
BMO Capital analyst Kostas Biliouris raised the price target on Sarepta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Kostas Biliouris raised the price target on Sarepta ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
